Esther van den Boom - 15 Sep 2022 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Sep 2022, 18:17:23 UTC
Prior SEC filing
08 Sep 2022
Next SEC filing
15 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ali D. Fawaz, Attorney-in-Fact

Key filing fact

Esther van den Boom filed Form 4 for Tyra Biosciences, Inc. (TYRA) on 19 Sep 2022.

Key facts

  • This page summarizes Esther van den Boom's Form 4 filing for Tyra Biosciences, Inc. (TYRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Sep 2022, 18:17.

Change

  • Previous filing in this sequence was filed on 08 Sep 2022.
  • Current net transaction value: +$11,120.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TYRA transaction

Common Stock

Award

Transaction value
$11,120
Shares
+1,452
Change %
+1.2%
Price
$7.66
Shares after
121,897
Date
15 Sep 2022
Ownership
Direct
Footnotes
F1
TYRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
118,645
Date
15 Sep 2022
Ownership
See footnote
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.

Footnote F2

Represents shares held by van den Boom Ventures LLC, of which the spouse of the Reporting Person is the managing member.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .